Guest guest Posted August 1, 2007 Report Share Posted August 1, 2007 Zebrafish study may point way to blindness cure By Ben Hirschler Wed Aug 1, 2:25 AM ET LONDON (Reuters) - The ability of zebrafish to regenerate damaged retinas has given scientists a clue about restoring human vision and could lead to an experimental treatment for blindness within five years. British researchers said on Wednesday they had successfully grown in the laboratory a type of adult stem cell found in the eyes of both fish and mammals that develops into neurons in the retina. In future, these cells could be injected into the eye as a treatment for diseases such as macular degeneration, glaucoma and diabetes-related blindness, according to Astrid Limb of University College London's (UCL) Institute of Ophthalmology. Damage to the retina -- the part of the eye that sends messages to the brain -- is responsible for most cases of sight loss. " Our findings have enormous potential, " Limb said. " It could help in all diseases where the neurons are damaged, which is basically nearly every disease of the eye. " Limb and her colleagues studied so-called Mueller glial cells in the eyes of people aged from 18 months to 91 years and found they were able to develop them into all types of neurons found in the retina. They were also able to grow them easily in the lab, they reported in the journal Stem Cells. The cells have already been tested in rats with diseased retinas, where they successfully migrated into the retina and took on the characteristics of the surrounding neurons. Now the team is working on the same approach in humans. " We very much hope that we could do autologous transplants within five years, " Limb told Reuters. Autologous transplants, initially on a trial basis, will involve manipulating cells and injecting them back into an individual's own eye. Eventually, Limb hopes it will also be possible to transfer the cells between different people. " Because they are so easy to grow, we could make stem cell banks and have cell lines available to the general population, subject to typing as with blood transfusions, " she said. Just why zebrafish have an abundant supply of adult stem cells to regenerate their retinas, while they are rare in mammals, remains a mystery but Limb suspects it is because mammals have a limiting system to stop proliferation. The new work on Mueller glial cells is the latest example of researchers exploring the potential of different kinds of stem cells in treating eye disease. Another team from UCL and Moorfield's Eye Hospital said in June they aimed to repair damaged retinas with cells derived from embryonic stem cells. http://news./s/nm/20070801/hl_nm/blindness_fish_dc ----------- Source: Rice University August 1, 2007 More on: Developmental Biology, Human Biology, Genes, Gene Therapy, Genetics, Life Sciences Zebrafish Research Provides Answers About Neurological Development Science Daily — Zebrafish cost about a dollar at the pet store. They grow from eggs to hunting their own food in three days. Adults can lay up to 500 eggs at once... and you have more in common with them than you think. " For all their differences, humans and zebrafish aren't that dissimilar, " said Rice University zebrafish expert Mary Ellen Lane. " For every zebrafish gene we isolate, there is a related gene in humans. " In her most recent work, Lane, graduate students Catherine McCollum and Shivas Amin, and undergraduate Philip Pauerstein zeroed in on a gene called LMO4 that's known to play roles in both cell reproduction and in breast cancer. Using the tools of biotechnology, the team studied zebrafish that couldn't transcribe the LMO4 gene, and they observed marked enlargement in both the forebrain and optical portions of the embryos. When they overexpressed the LMO4 gene, making more protein than normal, those same areas shrank. " The study suggests that LMO4 independently regulates two other genes that promote growth in those areas of the embryo, " said Lane, assistant professor of biochemistry and cell biology. " It fills in another piece of the bigger picture of what's going on during neurological development. " Zebrafish -- like rats and fruit flies before them -- are becoming regular contributors on research ranging from cancer to cocaine addiction. For example, zebrafish were used a landmark 2005 study that led scientists to the human gene that regulates skin color. Lane's zebrafish studies explore one the major unexplained areas in developmental biology -- how the brain and central nervous system develop. It helps that zebrafish embryos grow from just a single cell to having a forebrain, hindbrain, spinal column and eye within a scant 24 hours. It also helps that the embryos are transparent and develop outside their mothers' bodies -- and can thus been seen under a microscope at every step of their development. " It's a beautiful organism for experiment, " Lane said. " It develops in a very regular way, so any abnormality is easy to spot, even for undergraduates with only a few days training. " The study will appear later this year in the journal Developmental Biology. Note: This story has been adapted from a news release issued by Rice University. http://www.sciencedaily.com/releases/2007/07/070730111642.htm -- Public release date: 30-Jul-2007 [ Print Article '); // --> Print Article | E-mail Article Close Window'); // --> | Close Window ] Contact: Justin Walden jawalden 570-271-8083 Geisinger Health System Geisinger scientist seeks cure for Lou Gehrig's disease, creating device to find treatment Researcher teams with college students DANVILLE- A small tropical fish, the curiosity of a Geisinger research scientist and some college students have created the perfect storm of sorts in an attempt to find a cure for one of the world’s most devastating neurological diseases. On initial glance, there doesn’t seem to be much in common between zebrafish, researcher Glenn S. Gerhard, MD and a trio of Bucknell University biomedical engineering students. Yet they’re each playing a critical role in clearing a major roadblock in the search for a cure for Lou Gehrig's disease. Lou Gehrig's disease-or ALS or amyotrophic lateral sclerosis— is a fatal neurodegenerative condition that affects nerve cells in the brain and the spinal cord. As many as 20,000 Americans suffer from ALS and about 5,000 people in the U.S. are diagnosed with the disease each year, according to the National Institutes of Health. It’s an aging-related disease that has long fascinated Gerhard, a staff scientist in Geisinger’s Weis Center for Research. Gerhard believes that the cure for the disease—or at least a more viable treatment option—can be found in the right mix of the millions of drugs and drug compounds that have been developed in laboratories across the world. “There are so many different compounds but you don’t know which ones to test,” Gerhard says. “We need bioengineering help to automate this process.” That’s why Gerhard turned to the zebrafish and Bucknell University professor Joe Tranquillo and students Erica Andreozzi, Meredith Kalman and Emily Thiel. Several years ago, Gerhard started using the zebrafish, which can be easily bred and tends to exhibit disease’s effects at an accelerated rate. Yet the instruments needed to use these small and inexpensive fish for finding new drugs have not yet been brought to market. The students have developed a working prototype screening plate that allows scientists to quickly expose zebrafish to ALS and mix chemicals together. What once took weeks or months to screen thousands of potential cure-carrying chemical solutions may soon take days, and with far fewer research staff involved. A streamlined screening process will free up precious resources in the lab, Gerhard says. The Bucknell students worked throughout the spring semester to improve on their design. “In their first three years, Bucknell biomedical engineering students compile an excellent set of technical and design skills through a number of open-ended experiences,” Tranquillo says. “But they truly become engineers in their senior year when they meet with a medical professional, identify a real problem and spend a year solving that problem. The rich and educational interactions between Dr. Gerhard, Erica, Meredith and Emily were extraordinary to witness. ” Geisinger Ventures, which is the health system’s corporate development arm, arranged the partnership between Gerhard and the Bucknell team. Ventures is now seeking a corporate partner willing to license the invention for production and distribution. Geisinger Ventures nurtures innovative ideas, licenses and brings to market intellectual property, develops business plans, and catalyzes growth of for-profit companies. Gerhard’s work fits perfectly into Geisinger Ventures’ mission, says director Bryan Allinson. “Ventures-worthy ideas generally are focused on a better way to use a device, a piece of equipment or a process,” Allinson says. “The work with zebrafish has the potential to identify therapeutics that could help the thousands of people who suffer from ALS.” In the disease’s early stage, symptoms may be so hard to detect that the disease gets overlooked. But by the end stages of the disease, the patients are totally paralyzed. “ALS is a terrible disease,” Gerhard says. “Your brain is fine but your body and your muscles just waste away.” http://www.eurekalert.org/pub_releases/2007-07/ghs-gss073007.php ------ Fussy? Opinionated? Impossible to please? Perfect. Join 's user panel and lay it on us. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.